Interleukin-18 (IL-18) and matrix metalloproteinase-9 (MMP-9) in post-menopausal osteoporosis

Archives of Gerontology and Geriatrics

Volumn 40, Issue 3, 2005, Pages 299-305

  Maugeri, D ^a   Mamazza, C ^a   Lo Giudice, F ^a   Puglisi, N ^a   Muscoso, E G ^a   Rizzotto, M ^a   Testai M ^a   Bennati, E ^a   Lentini, A ^a   Panebianco, P ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Alendronate; BMD; IL 18; MMP 9; Raloxifene; Risedronate

Indexed keywords

ALENDRONIC ACID; GELATINASE B; INTERLEUKIN 18; RALOXIFENE; RISEDRONIC ACID;

ADULT; BONE DENSITY; CIRCULATION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MEASUREMENT; OSTEOPOROSIS; PATIENT; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVIEW;

EID: 20144388001     PISSN: 01674943     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.archger.2004.10.001     Document Type: Article

References (28)

1. G.J. Atkins, D.R. Haynes, S.M. Geary, M. Loric, T.N. Crotti, and D.M. Findlay Coordinated cytokine expression by stromal and hematopoietic cells during human osteoclast formation Bone 26 2000 653 661
2. M.S. Bendre, D.C. Montague, T. Peery, N.S. Akel, D. Gaddy, and L.J. Suva Interleukin-8 stimulation of osteoclastogenesis and bone resorption is a mechanism for the increased osteolysis of metastatic bone Bone 33 2003 28 37
3. D.M. Black, D.E. Thompson, D.C. Bauer, K. Ensrud, T. Musliner, M.C. Hochberg, M.C. Nevitt, S. Suryawanshi, and S.R. Cummings Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial (FIT) Research Group J. Clin. Endocrinol. Metab. 85 2000 4118 4124
4. B. Ettinger, D.M. Black, B.H. Mitlak, R.K. Knickerbocker, T. Nickelsen, H.K. Genant, C. Christiansen, P.D. Delmas, J.R. Zanchetta, J. Stakkestad, C.C. Gluer, K. Krueger, F.J. Cohen, S. Eckert, K.E. Ensurd, L.V. Avioli, P. Lips, and S.R. Cummings Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators J. Am. Med. Assoc. 282 1999 637 645
5. S.T. Harris, N.B. Watts, H.K. Genant, C.D. McKeever, T. Hangartner, M. Keller, C.H. Chesnut, J. Brown, E.F. Eriksen, M.S. Hoseyni, D.W. Axelrod, and P.D. Miller Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group J. Am. Med. Assoc. 282 1999 1344 1352
6. P. Heikkila, O. Teronen, M.Y. Hirn, T. Sorsa, T. Tervahartiala, T. Salo, Y.T. Konttinen, T. Halttunen, M. Moilanen, R. Hanemaaijer, and M. Laitinen Inhibition of matrix metalloproteinase-14 in osteosarcoma cells by clodronate J. Surg. Res. 111 2003 45 52
7. K. Hosohara, H. Ueda, S. Kashiwamura, T. Yano, T. Ogura, S. Marukawa, and H. Okamura Interleukin-18 induces acute biphasic reduction in the levels circulating leucocytes in mice Clin. Diagn. Lab. Immunol. 9 2002 777 783
8. K. Joronen, H. Salminen, V. Glumoff, M. Savontaus, and E. Vuorio Tempo-rospatial expression of tissue inhibitor of matrix metelloproteinases-1, 2 and 3 during development, growth and aging of the mouse skeleton Histochem. Cell. Biol. 114 2000 157 165
9. L. Liu, F.M. He, L.L. Li, and J.A. Hu The expression of MMP-9, MMP-2 in the remodeling bone tissue around implant during unloaded period Hua Xi Kou Qiang Yi Xue Za Zhi 22 2004 325 327 (in Chinese)
10. C. Makiishi-Shimobayashi, T. Tsujimura, T. Iwasaki, N. Yamada, A. Sugihara, H. Okamura, S. Hayashi, and N. Terada Interleukin-18 upregulates osteo-protegerin expression in stromal/osteoblastic cells Biochem. Biophys. Res. Commun. 281 2001 361 366
11. T.J. Martin, E. Romas, and M.T. Gillespie Interleukins in the control of osteoclast differentiation Crit. Rev. Eukaryot. Gene Expr. 8 1998 107 123
12. N. Mori, H. Sato, T. Hayashibara, M. Senba, T. Hayashi, Y. Yamada, S. Kamihira, S. Ikeda, Y. Yamasaki, S. Morikawa, M. Tomonaga, R. Geleziunas, and N. Yamamoto Human T-cell leukemia virus type I tax transactivates the matrix metallo-proteinase-9 gene: potential role in mediating adult T-cell leukemia invasiveness Blood 99 2002 1341 1349
13. M. Nold, A. Goede, W. Eberhardt, J. Pfeilschifter, and H. Muhl IL-18 initiates release of matrix metalloproteinase-9 from peripheral blood mononuclear cells without affecting tissue inhibitor of matrix metalloproteinase-1: suppression by TNF-α blockage and modulation by IL-10 Naunyn-Schmiedbergs Arch. Pharmacol. 367 2003 68 75
14. S. Onodera, J. Nishihira, K. Iwabuchi, Y. Koyama, K. Yoshida, S. Tanaka, and A. Minami Macrophage migration inhibitory factor upregulates matrix metalloproteinase-9 and -13 in rat osteoblast. Relevance to intracellular signaling pathways J. Biol. Chem. 277 2002 7865 7874
15. N. Ortega, D. Behonic, D. Stickens, and Z. Werb How proteases regulate bone morphogenesis Ann. N.Y. Acad. Sci. 995 2003 109 116
16. V. Paikka, P. Lehenkari, M.L. Sassi, J. Hallen, J. Risteli, P. Harkonen, and H.K. Vaananen Estrogen reduces the depth of resorption pits by disturbing the organic bone matrix degradation activity of mature osteoclasts Endocrinology 142 2001 5371 5378
17. A.V. Rouselle, C. Damiens, E. Grimaud, Y. Fortun, M. Padrines, N. Passuti, and D. Heymann Potential synergies between matrix proteins and soluble factors on resorption and proteinase activities of rabbit bone cells Histol. Histopathol. 16 2001 727 734
18. H. Sasaki, K. Balto, N. Kawashima, J. Eastcott, K. Hoshino, and S. Akira Gamma interferon (IFN-gamma) and IFN-gamma-inducing cytokines interleukin-12 (IL-12) and IL-18 do not augment in stimulated bone resorption in vivo Clin. Diagn. Lab. Immunol. 11 2004 106 110
19. G. Simsek, Y. Karter, S. Aydin, and H. Uzun Osteoporotic cytokines and bone metabolism on rats with inducing hyperthyroidism: changes as a result of reversal to euthyroidism Chin. J. Physiol. 46 2003 181 186
20. I. Stamenkovic Extracellular matrix remodeling: the role of matrix metallo-proteinases J. Pathol. 200 2003 448 464
21. Y. Suzuki Stimulator of bone resorption interleukin-1, interleukin-6 and gp-130 cytokine family Nippon Rinsho 62 Suppl. 2 2004 107 111 (in Japanese)
22. N. Udagawa, N.J. Horwood, J. Ellitt, A. Mackay, J. Owens, H. Okamura, M. Kurimoto, T.J. Chambers, T.J. Martin, and M.T. Gillespie Interleukin-18 (interferon-gamma-inducing factor) is produced by osteoblasts and acts via granulocyte/macrophage colony-stimulating factor and not via interferon-gamma to inhibit osteoclast formation J. Exp. Med. 185 1997 1005 1012
23. H. Valleala, R. Hanemaaijer, J. Mandelin, A. Salminen, O. Teronen, J. Monkonnen, and Y.T. Konttinen Regulation of MMP-9 (gelatinase B) in activated human monocyte/macrophages by two different types of bisphosphonates Life Sci. 73 2003 2413 2420
24. J.E. Wang, S. Pettersen, J.F. Stuestol, Y.Y. Wang, S.J. Foster, C. Thiemermann, A.O. Aasen, and K. Bjornland Peptidoglycan of S. aureus causes increased level matrix metalloproteinases in the rat Shock 22 2004 376 379
25. Y. Wittrant, S. Couillaud, S. Theoleyre, C. Dunstan, D. Heymann, and F. Redini Osteoprotegerin differentially regulates protease expression in osteoclast cultures Biochem. Biophys. Res. Commun. 293 2002 38 44
26. S. Wolczynski, A. Surazynski, J. Swiatecka, and J. Palka Estrogenic and anti-estrogenic effects of raloxifene on collagen metabolism in breast cancer MCF-7 cells Gynecol. Endocrinol. 15 2001 225 233
27. N. Yamada, S. Niwa, T. Tsjimura, T. Iwasaki, A. Sugihara, H. Futani, S. Hayashi, H. Okamura, H. Akedo, and N. Terada Interleukin-18 and interleukin-12 synergistically inhibit osteoclastic bone-resorbing activity Bone. 30 2002 901 908
28. H. Zhao, Z. Xia, G. Cai, J. Du, T. Zhu, and L. Shen Expression of type-I collagen and matrix metallopreoteinase-9 mRNA in bone of castrated adult femal rats: effects of estrogen Chin. Med. J. 111 1998 551 555